News & Updates
Filter by Specialty:
Extended letrozole therapy improves DFS in postmenopausal women with breast cancer
Extending treatment with letrozole for 5 years improves disease-free survival (DFS) rates in postmenopausal women with early-stage breast cancer who have already received tamoxifen for 2–3 years, according to the GIM4* trial.
Extended letrozole therapy improves DFS in postmenopausal women with breast cancer
06 Oct 2021
HCC in SG: NASH aetiology on the rise, curative therapy more accessible
Hepatocellular carcinoma (HCC) in Singapore has changed markedly throughout the last decade, with patients being diagnosed at an increasingly older age and cryptogenic cirrhosis/nonalcoholic steatohepatitis (NASH) becoming a more important aetiology, according to a recent study.
HCC in SG: NASH aetiology on the rise, curative therapy more accessible
05 Oct 2021
Leuprolide acetate maintains QOL scores in prostate cancer patients despite worsening condition
Treatment with leuprolide acetate every 6 months does not elicit significant changes in health-related quality of life (HRQOL) among prostate cancer (PC) patients despite substantial deterioration of body and role functions, a recent study has found.
Leuprolide acetate maintains QOL scores in prostate cancer patients despite worsening condition
05 Oct 2021
COVID-19 in childhood cancer patients: What are the risk factors?
A large international database study has shown that children and adolescents with cancer have an elevated risk of severe or critical disease if infected with COVID-19. Furthermore, about half the patients receiving cancer therapy experienced modifications to their treatment regimens.
